Ligand Pharmaceuticals | LGND - Trade Creditors


Ligand Pharmaceuticals reported $27.76M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Amgen USD 19.64B 1.61B Sep/2025
Arrowhead Research USD 32.94M 15.26M Dec/2025
Baxter International USD 953M 42M Sep/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Eli Lilly USD 4.26B 186.5M Sep/2025
Gilead Sciences USD 808M 226M Sep/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Glaxosmithkline GBP 21.07B 7.42B Sep/2025
Insmed USD 79.59M 1.24M Sep/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
Ligand Pharmaceuticals USD 27.76M 1.72M Sep/2025
MacroGenics USD 5.94M 1.28M Sep/2025
Merck USD 4.15B 102M Sep/2025
Pacira USD 17.69M 12.44M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Veracyte USD 5.51M 5.94M Sep/2025